Início › Câncer de Rim (Carcinoma de Células Renais) › Michigan

Ensaios clínicos de Câncer de Rim (Carcinoma de Células Renais) em Michigan

29 estudos para Câncer de Rim (Carcinoma de Células Renais) estão buscando participantes em locais em Michigan.

Cidades em Michigan

Texto oficial do estudo (Inglês)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Research Site, Detroit
Research Site, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NEO-811 Grand Rapids Site, Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07300241

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

South Texas Accelerated Research Therapeutics (START), Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
e mais 68

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #65, Detroit
Exelixis Clinical Site #13, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health Medical Center - Brighton, Brighton
e mais 32

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Local Institution - 0176, Big Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07293351

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

START Midwest, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05267626

Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA

Henry Ford Health, Detroit

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07828704

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
University of Michigan Rogel Cancer Center, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
e mais 12

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

University of Michigan, Ann Arbor

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Cancer & Hematology Centers of Western Michigan, Grand Rapids

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Bronson Battle Creek, Battle Creek
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
e mais 17

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06661720

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07115043

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

University of Michigan, Ann Arbor

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06966024

A Study of MGC026 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

University of Michigan Comprehensive Cancer Center, Ann Arbor

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06866262

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Henry Ford Cancer Institute, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Henry Ford Health, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT03972657

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT07383441

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Henry Ford Health System, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT06026410

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

University of Michigan, Ann Arbor

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT06053658

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Start Midwest Cancer Research, Grand Rapids

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT06413680

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Henry Ford Cancer Institute, Detroit

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 17 de dez. de 2025 · NCT05856981

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

University of Michigan Hospitals, Ann Arbor

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

University of Michigan Comprehensive Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
University of Michigan - Brighton Center for Specialty Care, Brighton
e mais 15

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2025 · NCT04510597

A Beta-only IL-2 ImmunoTherapY Study

Karmanos Cancer Institute, Detroit

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2025 · NCT05086692

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Michigan Hematology & Oncology Consultants - MedOnc Dearborn, Dearborn
Michigan Hematology & Oncology Consultants - MedOnc Troy, Troy

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de dez. de 2024 · NCT06281678

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.